Meeting Mic

Author: Healio

While annual major scientific meetings are the venue to stay up-to-date in your clinical area, it is near impossible to attend all breaking news sessions. Through interviews with experts, Healios Meeting Mic provides a post-meeting wrap-up of the most important content that listeners can consume on-the-go.
Be a guest on this podcast

Language: en

Genres: Health & Fitness, Life Sciences, Medicine, Science

Contact email: Get it

Feed URL: Get it

iTunes ID: Get it

Get all podcast data

Listen Now...

Highlights from ASCO Annual Meeting 2025
Episode 20
Tuesday, 17 June, 2025

In this episode of Meeting Mic, we bring you pearls and perspectives from the 2025 ASCO Annual Meeting, as well as Healio’s top headlines from the meeting. Chinmay Jani, MD, discusses findings highlighting how alcohol-related cancer mortality has risen sharply over the past few decades. :19 Rachel I. Vogel, PhD, provides and overview on factors contributing to the time burden cancer care places on patients. 3:02 Alexander D. Sherry, MD, discusses how improvements in OS or quality of life after phase 3 oncology trials are based on improvements in unvalidated alternative endpoints. 4:41 Lucas A. Mavromatis, ScB, discusses findings on how GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes. 7:20 Sonali M. Smith, MD, talks with Oncology Overdrive host Shikha Jain, MD, about presentations on lymphoma at this year’s ASCO meeting. 9:57 Read the full coverage here: https://www.healio.com/news/hematology-oncology/20250531/study-reveals-shocking-rise-in-alcoholrelated-cancer-deaths https://www.healio.com/news/hematology-oncology/20250603/time-burden-people-with-cancer-face-often-vastly-underestimated https://www.healio.com/news/hematology-oncology/20250604/few-phase-3-oncology-trials-demonstrate-improvements-in-os-quality-of-life https://www.healio.com/news/hematology-oncology/20250522/glp1-receptor-agonists-confer-modest-protection-against-obesityrelated-cancers https://www.healio.com/news/hematology-oncology/podcasts/oncology-overdrive/episode-119 Exercise described as ‘novel, first-in-class’ colon cancer therapy Source: Booth CM, et al. Abstract LBA3510. Presented at: ASCO Annual Meeting; May 30-June 3, 2025; Chicago. At-home intervention has potential to enhance cancer care delivery, outcomes Source: Nipp RD, et al. Abstract 11003. Presented at: ASCO Annual Meeting; May 30-June 3, 2025; Chicago. Disclosures: Jani reports no relevant financial disclosures. Mavromatis reports no relevant financial disclosures. Sherry reports honoraria from Sermo. Smith reports no relevant financial disclosures. Vogel reports a consulting/advisory role with Voluntis.